128 related articles for article (PubMed ID: 15987454)
1. Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.
Lanteri M; Ollier L; Giordanengo V; Lefebvre JC
Breast Cancer Res; 2005; 7(4):R487-94. PubMed ID: 15987454
[TBL] [Abstract][Full Text] [Related]
2. Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.
Aubert M; Crotte C; Bernard JP; Lombardo D; Sadoulet MO; Mas E
Int J Cancer; 2003 Dec; 107(6):910-8. PubMed ID: 14601050
[TBL] [Abstract][Full Text] [Related]
3. Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing.
Yoshimura N; Sawada T; Furusawa M; Fuchinoue S
Cancer Lett; 2001 Mar; 164(2):155-60. PubMed ID: 11179830
[TBL] [Abstract][Full Text] [Related]
4. Relationship between alphaGal epitope expression and decrease of tumorigenicity in pancreatic adenocarcinoma model.
Aubert M; Crotte C; Benkoel L; Panicot-Dubois L; Bernard JP; Lombardo D; Sadoulet MO; Mas E
Mol Carcinog; 2005 Apr; 42(4):202-12. PubMed ID: 15761838
[TBL] [Abstract][Full Text] [Related]
5. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
6. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
Sadoulet MO; Franceschi C; Aubert M; Silvy F; Bernard JP; Lombardo D; Mas E
Glycobiology; 2007 Jun; 17(6):620-30. PubMed ID: 17374617
[TBL] [Abstract][Full Text] [Related]
7. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
[TBL] [Abstract][Full Text] [Related]
8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
9. No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.
Ramm R; Hartmann T; Tudorache I; Haverich A; Hilfiker A
Xenotransplantation; 2015; 22(5):345-55. PubMed ID: 26301779
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Gal(alpha)1-3Gal(beta)1-4GlcNAc-R (alphaGal) expression on porcine valve endothelial cells.
Farivar RS; Filsoufi F; Adams DH
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):306-14. PubMed ID: 12579099
[TBL] [Abstract][Full Text] [Related]
12. Specificity profile of αGal antibodies in αGalT KO mice as probed with comprehensive printed glycan array: Comparison with human anti-Galili antibodies.
Dobrochaeva K; Khasbiullina N; Shilova N; Knirel Y; Obukhova P; Nokel A; Kunetskiy R; Tsygankova S; Bello-Gil D; Costa C; Mañez R; Bovin N
Xenotransplantation; 2021 May; 28(3):e12672. PubMed ID: 33432698
[TBL] [Abstract][Full Text] [Related]
13. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
[TBL] [Abstract][Full Text] [Related]
14. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
[TBL] [Abstract][Full Text] [Related]
15. Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.
Koike C; Uddin M; Wildman DE; Gray EA; Trucco M; Starzl TE; Goodman M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):559-64. PubMed ID: 17194757
[TBL] [Abstract][Full Text] [Related]
16. A positive role for PEA3 in HER2-mediated breast tumour progression.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
[TBL] [Abstract][Full Text] [Related]
17. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
[TBL] [Abstract][Full Text] [Related]
19. The influence of natural antibody specificity on antigen immunogenicity.
Benatuil L; Kaye J; Rich RF; Fishman JA; Green WR; Iacomini J
Eur J Immunol; 2005 Sep; 35(9):2638-47. PubMed ID: 16082726
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
